Applied Biosystems Completes Equity Investment in VisiGen
Complete the form below to unlock access to ALL audio articles.
Applied Biosystems Group, an Applera Corporation business, has announced that it has completed its previously announced equity investment in privately held VisiGen Biotechnologies.
Concurrent with its investment, Applied Biosystems also entered into a scientific collaboration agreement with VisiGen.
The VisiGen investment is part of Applied Biosystems’ strategy of maintaining its position in DNA sequencing by complementing its internal investments in new and existing sequencing technologies with promising next-generation approaches.
VisiGen’s technological approach to DNA sequencing is based on the ability to analyze a single molecule of DNA in real-time.